Legal status · United States
Is Dimethyl fumarate legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Dimethyl fumarate is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.
Dimethyl fumarate in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Approved for relapsing multiple sclerosis. Requires lymphocyte monitoring because of progressive multifocal leukoencephalopathy risk with prolonged lymphopenia. No ageing indication. |
| FDA approval status | FDA-approved as Tecfidera for relapsing forms of multiple sclerosis. Not approved for any ageing indication. |
| Human studies cited | 0 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Dimethyl fumarate profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Dimethyl fumarate for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Dimethyl fumarate is
An approved multiple sclerosis drug and the cleanest available NRF2 activator. It did not extend mouse lifespan, and the paper reports the dose delivered averaged only 35 percent of target, which the authors say may explain that.
NRF2 is the master transcriptional regulator of the antioxidant and detoxification response, and activating it is one of the most cited mechanisms in longevity supplementation. Sulforaphane, curcumin and a long list of plant compounds are all sold on this basis.
Mechanism: An electrophile that modifies cysteine residues on KEAP1, the protein that normally tags NRF2 for degradation. Disabling KEAP1 lets NRF2 accumulate and enter the nucleus, where it drives transcription of antioxidant response element genes including glutathione synthesis enzymes, NAD(P)H quinone dehydrogenase 1 and haem oxygenase 1.
Regulatory history: FDA-approved as Tecfidera for relapsing forms of multiple sclerosis. Not approved for any ageing indication.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Dimethyl fumarate at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Dimethyl fumarate in other countries
Frequently asked questions
Is Dimethyl fumarate legal in the United States?
Yes. Dimethyl fumarate is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile. Note: Approved for relapsing multiple sclerosis. Requires lymphocyte monitoring because of progressive multifocal leukoencephalopathy risk with prolonged lymphopenia. No ageing indication.
Can I buy Dimethyl fumarate in the United States?
Only with a prescription. Dimethyl fumarate is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Approved for relapsing multiple sclerosis. Requires lymphocyte monitoring because of progressive multifocal leukoencephalopathy risk with prolonged lymphopenia. No ageing indication.
Is Dimethyl fumarate FDA approved?
Yes. FDA status: FDA-approved as Tecfidera for relapsing forms of multiple sclerosis. Not approved for any ageing indication.. Current US classification: "FDA-approved, prescription only". On the evidence, no human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Dimethyl fumarate live on its compound profile.
Dimethyl fumarate profileThis page is general information about the regulatory status of Dimethyl fumarate in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.